INS and metabolic syndrome: A decreased insulin sensitivity manifests itself in a reduced insulin-stimulated glucose uptake, reduced insulin-suppression of endogenous glucose production, reduced antilipolysis, decreased insulin-induced vasodilation, dyslipidemia, and platelet hyperaggregability [32].